Last reviewed · How we verify

NCT05952349

Effect of Metformin and Combination of Olive Oil Plus Nutritional Supplements on Inflammatory Markers IL-6 and IL-8 in PCOS.

Completed Phase 2 Last updated 19 September 2024
What this trial tests

Phase 2 trial testing OLIVE OIL 5ML/5MG (BD) NUTRITIONAL SACHET 2100MG (BD) in PCO in 88 participants. Completed in 1 April 2024.

Timeline
1 July 2023
Primary endpoint
31 December 2023
1 April 2024

Quick facts

Lead sponsorKhyber Medical University Peshawar
PhasePhase 2
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment88
Start date1 July 2023
Primary completion31 December 2023
Estimated completion1 April 2024
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Khyber Medical University Peshawar

Who can join

Adults 18 to 34, female only, with PCO. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The investigators aim is to conduct randomized clinical trial, to determine the effects of metformin and combination of olive oil plus nutritional supplements on inflammatory markers IL-8 and IL6 in polycystic ovarian syndrome (PCOS). Women diagnosed with PCOS using "Rotterdam diagnostic criteria" according to which two out of three characters must be their in women of PCOS. The investigators propose that PCOS women have increase levels of IL-6 ,IL-8 and this therapy would have beneficial effects and is able to reduce their increase interleukins levels .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for PCO

Currently open trials in the same condition.

Other Khyber Medical University Peshawar trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05952349.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing